A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)

Mise à jour : Il y a 4 ans
Référence : NCT00075218

Femme et Homme

Extrait

A study to assess the safety and efficacy of SU11248 in patients with gastrointestinal stromal tumor (GIST) whose disease has failed imatinib therapy or who were intolerant to imatinib treatment.


Critère d'inclusion

  • Gastrointestinal stromal tumor


Liens